Lee Klarich - 04 Jun 2025 Form 4 Insider Report for Palo Alto Networks Inc (PANW)

Role
EVP, Chief Product Officer
Signature
/s/ Elizabeth Villalobos, Attorney-in-Fact for Lee Klarich
Issuer symbol
PANW
Transactions as of
04 Jun 2025
Net transactions value
-$20,600,774
Form type
4
Filing time
06 Jun 2025, 19:00:07 UTC
Previous filing
07 May 2025
Next filing
09 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Klarich Lee EVP, Chief Product Officer C/O PALO ALTO NETWORKS INC., 3000 TANNERY WAY, SANTA CLARA /s/ Elizabeth Villalobos, Attorney-in-Fact for Lee Klarich 06 Jun 2025 0001682260

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PANW Common Stock Options Exercise $2,967,322 +92,010 +31% $32.25 385,020 04 Jun 2025 Direct
transaction PANW Common Stock Sale $8,182,438 -42,191 -11% $193.94 342,829 04 Jun 2025 Direct F1, F2
transaction PANW Common Stock Sale $4,779,480 -24,526 -7.2% $194.87 318,303 04 Jun 2025 Direct F1, F3
transaction PANW Common Stock Sale $7,915,259 -40,378 -13% $196.03 277,925 04 Jun 2025 Direct F1, F4
transaction PANW Common Stock Sale $2,690,919 -13,679 -4.9% $196.72 264,246 04 Jun 2025 Direct F1, F5
holding PANW Common Stock 740,000 04 Jun 2025 See footnote F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PANW Stock Option (right to buy) Options Exercise $0 -92,010 -12% $0.000000 644,070 04 Jun 2025 Common Stock 92,010 $32.25 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 27, 2024.
F2 This sale price represents the weighted average sale price of the shares sold ranging from $193.48 to $194.475 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F3 This sale price represents the weighted average sale price of the shares sold ranging from $194.48 to $195.46 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F4 This sale price represents the weighted average sale price of the shares sold ranging from $195.485 to $196.48 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F5 This sale price represents the weighted average sale price of the shares sold ranging from $196.485 to $197.155 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F6 Shares are held by the Klarich 2005 Trust, for which the Reporting Person and his spouse serve as trustees.
F7 The shares subject to the option are fully vested and exercisable.